Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 458306 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 575162 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 593364 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 615297 | Peak area | HAHA | IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 643949 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 667524 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 670914 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 693705 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 762326 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 832208 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 854482 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 997478 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 1062695 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 1071709 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 1318204 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 3078 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 4217 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 4781 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 5036 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 5431 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 5637 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 6196 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 7332 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 7849 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 13098 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 15138 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | BS4 | Untreated | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | HAHA | TNF-alpha |